mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.2 |
mRNA |
rTRAIL |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.2 |
mRNA |
QL-XII-61 |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.2 |
mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |